cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.6084/m9.figshare.22591591.v1
title: Supplementary Material for: In utero exposure to valproic acid throughout pregnancy causes phenotypes of autism in offspring mice

description: Valproic acid (VPA) is an antiepileptic drug that inhibits the epileptic activity of neurons mainly by inhibiting sodium channels and GABA transaminase. VPA is also known to inhibit histone deacetylases, which epigenetically modify the cell proliferation/differentiation characteristics of stem/progenitor cells within developing tissues. Recent clinical studies in humans have indicated that VPA exposure in utero increases the risk of autistic features and intellectual disabilities in offspring; we previously reported that low-dose VPA exposure in utero throughout pregnancy increases the production of projection neurons from neuronal stem/progenitor cells that are distributed in the superficial neocortical layers of the fetal brain. In the present study, we found that in utero VPA-exposed mice exhibited abnormal social interaction, changes in cognitive function, hypersensitivity to pain/heat, and impaired locomotor activity, all of which are characteristic symptoms of autistic spectrum disorder in humans. Taken together, our findings indicate that VPA exposure in utero throughout pregnancy alters higher brain function and predisposes individuals to phenotypes that resemble autism and intellectual disability. Furthermore, these symptoms are likely to be due to neocortical dysgenesis that was caused by an increased number of projection neurons in specific layers of the neocortex.
DOI: 10.5281/zenodo.7995038
title: dataset

description: lista cloni
DOI: 10.5281/zenodo.7995037
title: dataset

description: lista cloni
DOI: 10.6084/m9.figshare.23276999
title: A Visible-Light-Driven Molecular Motor Based on Barbituric Acid

description: cartesian coordinates
DOI: 10.6084/m9.figshare.22349197
title: Supplementary Material for: Survival Trends in Sorafenib for Advanced Hepatocellular Carcinoma: A Reconstructed Individual Patient Data Meta-analysis of Randomized Trials

description: Background: Emerging data suggest that outcomes for advanced hepatocellular carcinoma (HCC) treated with sorafenib may have improved over time. We aimed to provide robust, time-to-event estimates of survival outcomes for sorafenib in advanced HCC. Summary: In this systematic review and individual patient data meta-analysis of randomized-controlled trials (RCTs), we searched MEDLINE and Embase from inception till September 2022 for RCTs that provided data for overall survival (OS) and progression-free survival (PFS) for sorafenib monotherapy as first-line systemic therapy for advanced HCC. We performed a pooled analysis using reconstructed individual participant data from published Kaplan-Meier curves to obtain robust estimates for OS and PFS. Of 1,599 articles identified, 29 studies (5,525 patients) met the inclusion criteria. Overall, the median OS was 10.4 (95% CI 9.6 – 11.4) months. Median OS increased over time, from 9.8 (95% CI 8.8¬ – 10.7) months in studies before 2015, to 13.4 (95% CI 11.03 – 15.24) months in studies from 2015 onwards, p&lt;0.001. OS did not differ by trial phase, geographical region, or study design. The overall median PFS was 4.4 (95% CI 3.9 – 4.8) months, but PFS did not improve over time. Sensitivity analysis of studies from 2015 and onwards to account for the introduction of direct-acting antivirals determined that hepatitis C virus was associated with reduced mortality (p&lt;0.001). There was minimal heterogeneity in the estimates for OS (all I2 ≤ 33). Key Messages: Survival outcomes for sorafenib in advanced HCC have improved over time. These data have important implications for clinical trial design.
DOI: 10.6084/m9.figshare.22349197.v1
title: Supplementary Material for: Survival Trends in Sorafenib for Advanced Hepatocellular Carcinoma: A Reconstructed Individual Patient Data Meta-analysis of Randomized Trials

description: Background: Emerging data suggest that outcomes for advanced hepatocellular carcinoma (HCC) treated with sorafenib may have improved over time. We aimed to provide robust, time-to-event estimates of survival outcomes for sorafenib in advanced HCC. Summary: In this systematic review and individual patient data meta-analysis of randomized-controlled trials (RCTs), we searched MEDLINE and Embase from inception till September 2022 for RCTs that provided data for overall survival (OS) and progression-free survival (PFS) for sorafenib monotherapy as first-line systemic therapy for advanced HCC. We performed a pooled analysis using reconstructed individual participant data from published Kaplan-Meier curves to obtain robust estimates for OS and PFS. Of 1,599 articles identified, 29 studies (5,525 patients) met the inclusion criteria. Overall, the median OS was 10.4 (95% CI 9.6 – 11.4) months. Median OS increased over time, from 9.8 (95% CI 8.8¬ – 10.7) months in studies before 2015, to 13.4 (95% CI 11.03 – 15.24) months in studies from 2015 onwards, p&lt;0.001. OS did not differ by trial phase, geographical region, or study design. The overall median PFS was 4.4 (95% CI 3.9 – 4.8) months, but PFS did not improve over time. Sensitivity analysis of studies from 2015 and onwards to account for the introduction of direct-acting antivirals determined that hepatitis C virus was associated with reduced mortality (p&lt;0.001). There was minimal heterogeneity in the estimates for OS (all I2 ≤ 33). Key Messages: Survival outcomes for sorafenib in advanced HCC have improved over time. These data have important implications for clinical trial design.
DOI: 10.5281/zenodo.7994913
title: Dataset - Fast mechanical and biochemical cell wall dynamics underlie plant nutation

description: Dataset and codes (Python and Matlab) used to produce the figures in the article "Fast mechanical and biochemical cell wall dynamics underlie plant nutation".
DOI: 10.5281/zenodo.7994912
title: Dataset - Fast mechanical and biochemical cell wall dynamics underlie plant nutation

description: Dataset and codes (Python and Matlab) used to produce the figures in the article "Fast mechanical and biochemical cell wall dynamics underlie plant nutation".
DOI: 10.5281/zenodo.7969851
title: Data for: The need to decipher plant drought stress along the soil-plant-atmosphere continuum

description: Dataset and R-Script accompanying the in OIKOS published manuscript: Schweiger <em>et al.</em> (2023) - The need to decipher plant drought stress along the soil-plant-atmosphere continuum Article DOI: <em><strong>10.1111/oik.10136 </strong></em> All data is provided within one excel file. Please, pay attention to the provided ReadMe sheet for information on the dataset. The R-Script allows to reproduce the presented results with the provided data.
DOI: 10.6084/m9.figshare.19426721
title: Genotype specific PEP - Fasta files

description: Genotype specific protein fasta files
DOI: 10.14284/603
title: How the Blue Economy affects plankton dynamics in the BPNS: data and scripts

description: Input data, R scripts and results of a mechanistic model that uses near real-time data from the Belgian Part of the North Sea (2011-2017) to investigate the effects of hypothetical mussel aquaculture and offshore wind farm scenarios in the BPNS.
description: This archive contains the input data, R scripts and final results of a mechanistic model that uses near real-time data from the Belgian Part of the North Sea (2011-2017) to investigate the effects of hypothetical mussel aquaculture and offshore wind farm scenarios in the BPNS. This study was performed in the scope of a master thesis for the International Master of Science in Marine Biological Resources (IMBRSea) conducted at Ugent in collaboration with VLIZ. Input data are zooplankton and phytoplankton abundances, nutrients, Sea Surface Temperature (SST), photosynthetically active radiation (PAR) from the LifeWatch data and infrastructure, funded by Research Foundation - Flanders (FWO). Water temperature data for one of the locations was obtained from Flemish Banks Monitoring Network at https://meetnetvlaamsebanken.be/.
DOI: 10.6084/m9.figshare.22820714.v1
title: Supplementary Material for: New Miniaturized System for Ultrafiltration: Rationale and Design of a Single-Center, Crossover, Randomized, Open-Label, Pilot Study Protocol

description: Introduction: Fluid overload and congestion are common features in patients with heart failure and are associated with negative clinical outcomes. Therapies for these conditions are diuretic-centered but frequently failure to achieve patient adequate hydration status, prompting the use of extracorporeal ultrafiltration. Artificial Diuresis 1, AD1, is a miniaturized, portable, and wearable system designed to deliver isolated ultrafiltration with the finest degree of simplicity and practicality. Methods/Design: Single-center, crossover, randomized, open-label pilot study to investigate the safety and the efficacy (concerning ultrafiltration accuracy) of extracorporeal ultrafiltration with the device AD1 in comparison to isolated ultrafiltration with a traditional machine (PrisMaX. Patients with chronic kidney disease stage 5D (on hemodialysis) or intensive care patients presenting acute kidney injury stage 3D (requiring hemodialysis) will carry out a single session of isolated ultrafiltration with each of the machines. The safety primary outcomes will be the occurrence of adverse events. The efficacy primary outcome will be the accuracy of ultrafiltration rate (delivered/prescribed) on each of the devices. Discussion/Conclusion: AD1 is a novel miniaturized device for extracorporeal ultrafiltration. This study will be the first-in-human use of AD1 in patients with fluid overload. Trial registration number: CESC Provincia di Vicenza_6.9.22(n.54/22)_1575_29.9.22
DOI: 10.6084/m9.figshare.19426715
title: Genotype specific CDS - Fasta files

description: Predicted coding sequences form 48 sugarcane transcriptomes
DOI: 10.6084/m9.figshare.23277213
title: Xenotime reveals Caledonian hydrothermal overprint on Neoproterozoic Cu mineralization, East Greenland

description: Supplementary Table B: Zircon U-Pb data for analyses from NOA0008 (quartzite) and GL01178 (muscovite-granodiorite).
DOI: 10.48493/c8ck-y827
title: Equine Biometry from Czech Medieval and Modern sites
DOI: 10.6084/m9.figshare.23277225.v1
title: Xenotime reveals Caledonian hydrothermal overprint on Neoproterozoic Cu mineralization, East Greenland

description: Supplementary Table C: Xenotime and monazite EPMA data for analyses from GL00670, GL00684 and GL00685 (all Cu ± Pb mineralized metasiltstones, including analyses from detrital matrix).
DOI: 10.13140/rg.2.2.29703.57760
title: Hypericum
DOI: 10.25919/9j8k-c395
title: CAPRIX - Atmospheric aerosol measurements from the RV Investigator voyage IN2021_V01

description: This data collection contains aerosol measurements taken aboard the voyage IN2021_V01 as part of the Cloud Aerosol Precipitation Radiation Interactions eXperiment (CAPRIX, Australian Antarctic Division). This voyage, spanning January - March 2021, departed Hobart and travelled over the Southern Ocean, extending a latitude of 68.0025°S to 42.8864°S and longitude of 54.9051°E to 147.3803°E. Data includes offline filter analysis and online aerosol chemical composition.
DOI: 10.57745/zuc52e
title: Source_Data_60.xls

description: qPCR experiment - StepOne Plus Real-Time PCR raw data - qPCR71
DOI: 10.57745/imnjmj
title: Source_Data_91.xls

description: qPCR experiment - StepOne Plus Real-Time PCR raw data - qPCR148
DOI: 10.57745/hvh0j3
title: Source_Data_61.xls

description: qPCR experiment - StepOne Plus Real-Time PCR raw data - qPCR72
DOI: 10.57745/3w9g9r
title: Source_Data_66.xls

description: qPCR experiment - StepOne Plus Real-Time PCR raw data - qPCR81
DOI: 10.57745/sba8on
title: Source_Data_49.xls

description: qPCR experiment - StepOne Plus Real-Time PCR raw data - qPCR35
DOI: 10.57745/aq9lwc
title: Source_Data_72.xls

description: qPCR experiment - StepOne Plus Real-Time PCR raw data - qPCR116
DOI: 10.57745/imowin
title: Source_Data_55.xls

description: qPCR experiment - StepOne Plus Real-Time PCR raw data - qPCR66
DOI: 10.57745/fp8wig
title: Source_Data_70.xls

description: qPCR experiment - StepOne Plus Real-Time PCR raw data - qPCR107
DOI: 10.57745/woblrf
title: Source_Data_87.xls

description: qPCR experiment - StepOne Plus Real-Time PCR raw data - qPCR149
DOI: 10.57745/nxq93c
title: Source_Data_74.xls

description: qPCR experiment - StepOne Plus Real-Time PCR raw data - qPCR133
DOI: 10.57745/sb87qo
title: Source_Data_56.xls

description: qPCR experiment - StepOne Plus Real-Time PCR raw data - qPCR67
DOI: 10.57745/lrnpbf
title: Source_Data_82.xls

description: qPCR experiment - StepOne Plus Real-Time PCR raw data - qPCR140
DOI: 10.57745/72qzqi
title: Source_Data_79.xls

description: qPCR experiment - StepOne Plus Real-Time PCR raw data - qPCR138
DOI: 10.57745/5qff8a
title: Source_Data_57.xls

description: qPCR experiment - StepOne Plus Real-Time PCR raw data - qPCR68
DOI: 10.57745/otedmq
title: Source_Data_80.xls

description: qPCR experiment - StepOne Plus Real-Time PCR raw data - qPCR139
DOI: 10.57745/crcgkt
title: Source_Data_62.xls

description: qPCR experiment - StepOne Plus Real-Time PCR raw data - qPCR73
DOI: 10.57745/vdhvsm
title: Source_Data_59.xls

description: qPCR experiment - StepOne Plus Real-Time PCR raw data - qPCR70
DOI: 10.57745/ge2wfm
title: Source_Data_68.xls

description: qPCR experiment - StepOne Plus Real-Time PCR raw data - qPCR86
DOI: 10.57745/imv8ys
title: Source_Data_51.xls

description: qPCR experiment - StepOne Plus Real-Time PCR raw data - qPCR38
DOI: 10.57745/xrxjkr
title: Source_Data_84.xls

description: qPCR experiment - StepOne Plus Real-Time PCR raw data - qPCR143
DOI: 10.57745/7z0kg1
title: Source_Data_58.xls

description: qPCR experiment - StepOne Plus Real-Time PCR raw data - qPCR69
DOI: 10.57745/z6gl9w
title: Source_Data_77.xls

description: qPCR experiment - StepOne Plus Real-Time PCR raw data - qPCR136
DOI: 10.57745/jn21ko
title: Source_Data_83.xls

description: qPCR experiment - StepOne Plus Real-Time PCR raw data - qPCR141
DOI: 10.57745/3giifh
title: Source_Data_67.xls

description: qPCR experiment - StepOne Plus Real-Time PCR raw data - qPCR85
DOI: 10.57745/qtp0k1
title: Source_Data_64.xls

description: qPCR experiment - StepOne Plus Real-Time PCR raw data - qPCR79
DOI: 10.57745/snj1um
title: Source_Data_69.xls

description: qPCR experiment - StepOne Plus Real-Time PCR raw data - qPCR106
DOI: 10.57745/yuvv1w
title: Source_Data_78.xls

description: qPCR experiment - StepOne Plus Real-Time PCR raw data - qPCR137
DOI: 10.57745/v1n2fc
title: Source_Data_90.xls

description: qPCR experiment - StepOne Plus Real-Time PCR raw data - qPCR147
DOI: 10.57745/lnfmsk
title: Source_Data_52.xls

description: qPCR experiment - StepOne Plus Real-Time PCR raw data - qPCR39
DOI: 10.57745/uhms1t
title: Source_Data_50.xls

description: qPCR experiment - StepOne Plus Real-Time PCR raw data - qPCR36
DOI: 10.57745/8jrsef
title: Source_Data_89.xls

description: qPCR experiment - StepOne Plus Real-Time PCR raw data - qPCR146
DOI: 10.57745/o2iaq2
title: Source_Data_92.xls

description: qPCR experiment - StepOne Plus Real-Time PCR raw data - qPCR150
DOI: 10.57745/z0hadw
title: Source_Data_53.xls

description: qPCR experiment - StepOne Plus Real-Time PCR raw data - qPCR40
DOI: 10.57745/sk6hgu
title: Source_Data_63.xls

description: qPCR experiment - StepOne Plus Real-Time PCR raw data - qPCR74
DOI: 10.6084/m9.figshare.21385787
title: Additional file 2 of Bile acid distributions, sex-specificity, and prognosis in colorectal cancer

description: Additional file 2: Table S3. Statistics of the abundances of bacteria in tumors from RCCs and LCCs.
DOI: 10.57745/pzgeby
title: Source_Data_81.xls

description: qPCR experiment - StepOne Plus Real-Time PCR raw data - qPCR142
DOI: 10.57745/qm5li8
title: Source_Data_65.xls

description: qPCR experiment - StepOne Plus Real-Time PCR raw data - qPCR80
DOI: 10.57745/eklcd7
title: Source_Data_75.xls

description: qPCR experiment - StepOne Plus Real-Time PCR raw data - qPCR134
DOI: 10.57745/agiqn8
title: Source_Data_86.xls

description: qPCR experiment - StepOne Plus Real-Time PCR raw data - qPCR151
DOI: 10.57745/bhwjll
title: Source_Data_85.xls

description: qPCR experiment - StepOne Plus Real-Time PCR raw data - qPCR144
DOI: 10.6084/m9.figshare.21385787.v1
title: Additional file 2 of Bile acid distributions, sex-specificity, and prognosis in colorectal cancer

description: Additional file 2: Table S3. Statistics of the abundances of bacteria in tumors from RCCs and LCCs.
DOI: 10.57745/47tbm1
title: Source_Data_88.xls

description: qPCR experiment - StepOne Plus Real-Time PCR raw data - qPCR145
DOI: 10.57745/jckv3r
title: Source_Data_76.xls

description: qPCR experiment - StepOne Plus Real-Time PCR raw data - qPCR135
DOI: 10.57745/7b7kgl
title: Supplementary_Data_08.tab

description: H1a1 haplogroup
DOI: 10.57745/balcnx
title: Supplementary_Data_16.html

description: Luciferase on HeLa cells - statistical analysis in R
DOI: 10.6084/m9.figshare.21385793
title: Additional file 4 of Bile acid distributions, sex-specificity, and prognosis in colorectal cancer

description: Additional file 4. Clinical information and bile acid values (dichotomized by medians) of individual patients.
DOI: 10.57745/xwuuma
title: Supplementary_Data_06.tab

description: List of mammalian species
DOI: 10.57745/2dwpkd
title: Supplementary_Data_15.html

description: Luciferase on HEK293T cells - statistical analysis in R
DOI: 10.57745/hdcil8
title: Supplementary_Data_07.xlsx

description: Genomatix predicted transcription binding sites
DOI: 10.57745/gsxsjx
title: Supplementary_Data_09.clc

description: Luciferase: annotated Plasmid-pcDNA3-Myc2X-NR5A1 - CLC main workbench file
DOI: 10.57745/c0hvnp
title: Supplementary_Data_04.clc

description: annotated SRY locus - CLC main workbench file
DOI: 10.6084/m9.figshare.21385793.v1
title: Additional file 4 of Bile acid distributions, sex-specificity, and prognosis in colorectal cancer

description: Additional file 4. Clinical information and bile acid values (dichotomized by medians) of individual patients.
DOI: 10.57745/vgkcyo
title: Supplementary_Data_01.clc

description: annotated SRY locus - CLC main workbench file
DOI: 10.57745/bjstgd
title: Supplementary_Data_02.clc

description: annotated SRY locus - CLC main workbench file
DOI: 10.57745/dbpdyr
title: Supplementary_Data_05.clc

description: annotated SRY locus - CLC main workbench file
DOI: 10.57745/kffehv
title: Supplementary_Data_10.clc

description: Luciferase: annotated Plasmid-pCMV-Renilla-AF025843 - CLC main workbench file
DOI: 10.57745/irsa8p
title: Supplementary_Data_03.clc

description: annotated SRY locus - CLC main workbench file
DOI: 10.57745/xckadn
title: Supplementary_Table_01.pdf

description: Case report for patients with DSD from the pedigree in Fig 3.
DOI: 10.57745/u1ge9o
title: Supplementary_Figure_01.pdf

description: Supplementary to Figure 02 : Phylogenetic tree of the mammalian species used to build figure 2
DOI: 10.57745/cwjxvm
title: Supplementary_Figure_02.pdf

description: Supplementary to Figure 03 : SRY mutant alleles Sanger sequencing
DOI: 10.57745/sfelhz
title: Supplementary_Figure_04.pdf

description: Supplementary to Figure 04 : SRY DNA NR5A1 protein interaction
DOI: 10.57745/0urn5z
title: Supplementary_Figure_03.pdf

description: Supplementary to Figure 03 : Coexpression of SRY, NR5A1 and SOX9 in the human developing gonad
DOI: 10.57745/iagxhl
title: Supplementary_Data_13.clc

description: "Luciferase: annotated Plasmid-pGL4.26_link5_pGL4.26_link5_E250-Variant-2
CLC main workbench file"
DOI: 10.57745/xelvnm
title: Supplementary_Data_14.clc

description: Luciferase: annotated Plasmid-pGL4.26_link5_E250-∆NR5A1 - CLC main workbench file
DOI: 10.57745/o8vpqz
title: Supplementary_Data_12.clc

description: "Luciferase: annotated Plasmid-pGL4.26_link5_pGL4.26_link5_E250-Variant-1
CLC main workbench file"
DOI: 10.57745/qrfv89
title: Supplementary_Data_11.clc

description: Luciferase: annotated Plasmid-pGL4.26_link5_E250-Reference - CLC main workbench file
DOI: 10.57745/y6u4ez
title: Supplementary_Data_19_.html

description: RT-qPCR analysis - SOX9 - Linear Mixed Model in R
DOI: 10.57745/ufseib
title: Supplementary_Data_21_.html

description: RT-qPCR analysis - NR5A1 - Linear Mixed Model in R
DOI: 10.57745/h0eswq
title: Supplementary_Data_22_.html

description: RT-qPCR analysis - FOXL2 - Linear Mixed Model in R
DOI: 10.57745/mlmv4d
title: Supplementary_Data_20_.html

description: RT-qPCR analysis - WNT4 - Linear Mixed Model in R
DOI: 10.57745/rez5qx
title: Supplementary_Data_18_.html

description: RT-qPCR analysis - SRY - Linear Mixed Model in R
DOI: 10.57745/yv4fzi
title: Supplementary_Data_17.tab

description: RT-qPCR analysis - AMH - Wild type versus mutant comparison
DOI: 10.57745/cbdyei
title: Supplementary_Data_23_.html

description: RT-qPCR analysis - FGF9 - Linear Mixed Model in R
DOI: 10.57745/czmer6
title: Supplementary_Data_28.tab

description: RT-qPCR analysis - FOXL2 - data preparation for Linear Mixed Model in R
DOI: 10.57745/uqlkgv
title: Supplementary_Data_33_.html

description: RT-qPCR analysis - NR5A1 - outlier identification by the IQR method in R
DOI: 10.57745/pyjkoj
title: Supplementary_Data_35_.html

description: RT-qPCR analysis - FGF9 - outlier identification by the IQR method in R
DOI: 10.57745/5mkk9l
title: Supplementary_Data_30_.html

description: RT-qPCR analysis - SRY - outlier identification by the IQR method in R
DOI: 10.57745/gwptgd
title: Supplementary_Data_26.tab

description: RT-qPCR analysis - WNT4 - data preparation for Linear Mixed Model in R
DOI: 10.57745/pjhamm
title: Supplementary_Data_32_.html

description: RT-qPCR analysis - WNT4 - outlier identification by the IQR method in R
DOI: 10.57745/7y9nhr
title: Supplementary_Data_31_.html

description: RT-qPCR analysis - SOX9 - outlier identification by the IQR method in R
DOI: 10.57745/hqjo3y
title: Supplementary_Data_27.tab

description: RT-qPCR analysis - NR5A1 - data preparation for Linear Mixed Model in R
DOI: 10.57745/feg5bv
title: Supplementary_Data_24.tab

description: RT-qPCR analysis - SRY - data preparation for Linear Mixed Model in R
DOI: 10.57745/sop99s
title: Supplementary_Data_25.tab

description: RT-qPCR analysis - SOX9 - data preparation for Linear Mixed Model in R
DOI: 10.57745/oxnyyz
title: Supplementary_Data_29.tab

description: RT-qPCR analysis - FGF9 - data preparation for Linear Mixed Model in R
DOI: 10.57745/etayzy
title: Supplementary_Data_34_.html

description: RT-qPCR analysis - FOXL2 - outlier identification by the IQR method in R
DOI: 10.57745/xg5jmw
title: Supplementary_Data_46.tab

description: RT-qPCR analysis - iPS26b-Wild type expression kinetics
DOI: 10.57745/t0bnyn
title: Supplementary_Data_44.tab

description: RT-qPCR analysis - iPS12-Wild type expression kinetics
DOI: 10.57745/mq5ome
title: Supplementary_Data_45.tab

description: RT-qPCR analysis - iPS26a-Wild type expression kinetics
DOI: 10.57745/7lb9id
title: Supplementary_Data_40.tab

description: RT-qPCR analysis - FOXL2 - Wild type versus mutant comparison
DOI: 10.57745/buurfu
title: Supplementary_Data_43.tab

description: RT-qPCR analysis - iPS09-Wild type expression kinetics
DOI: 10.57745/yqin1d
title: Supplementary_Data_42.tab

description: RT-qPCR analysis - iPS07-Wild type expression kinetics
DOI: 10.57745/wk8vaz
title: Supplementary_Data_39.tab

description: RT-qPCR analysis - NR5A1 - Wild type versus mutant comparison
DOI: 10.57745/l8gdlf
title: Supplementary_Data_36.tab

description: RT-qPCR analysis - SRY - Wild type versus mutant comparison
DOI: 10.57745/sx1jgd
title: Supplementary_Data_38.tab

description: RT-qPCR analysis - WNT4 - Wild type versus mutant comparison
DOI: 10.57745/zgye2i
title: Supplementary_Data_41.tab

description: RT-qPCR analysis - FGF9 - Wild type versus mutant comparison
DOI: 10.57745/rrqtzn
title: Supplementary_Data_47.pzfx

description: RT-qPCR analysis: GraphPad Prism file summarizing all RT-qPCR experiment results
DOI: 10.57745/hy28km
title: Supplementary_Data_37.tab

description: RT-qPCR analysis - SOX9 - Wild type versus mutant comparison